On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
NOTE: REVISED DATE Dr. Emmanouil Metzakopian leads a team at the UK DRI in Cambridge. The aim of his projects is to identify genes which confer resistance to cellular stress (oxidative and ER) and involved in synaptic maintenance in dopamine neurons. He received his PhD in midbrain development from University College London under the supervision of Dr. Siew-Lan Ang at the National Institute for Medical Research. Emmanouil has been working on genome scale genetic screens in neurodegeneration using the CRISPR-Cas9 gene editing tool in collaboration with the Wellcome Trust Sanger Institute. He was involved in designing and producing the first human and mouse CRISPR arrayed library and received the R&D 100 award for this achievement. This library is now distributed by SIGMA.
